Bausch Health Cos

Bausch Health Companies Inc., headquartered in CA and operating within the Pharmaceutical Preparation Manufacturing industry, reported its total carbon emissions for 2023 to be approximately 126.9 billion kg CO2e. This figure represents a sum of Scope 1, 2, and 3 emissions.

For 2023, Bausch Health Companies Inc. reported Scope 1 emissions of approximately 49.9 million kg CO2e and Scope 2 emissions (market-based) of approximately 52.0 million kg CO2e. Scope 3 emissions for the same year included approximately 27.1 million kg CO2e from waste generated in operations. The company notes that data for Scope 3, specifically purchased goods and services, was missing for this reporting period.

In 2022, the company's total carbon emissions were approximately 117.2 billion kg CO2e. This comprised approximately 46.7 million kg CO2e for Scope 1, approximately 50.5 million kg CO2e for Scope 2 (market-based), and approximately 19.3 million kg CO2e for Scope 3 from waste generated in operations. Similar to 2023, data for Scope 3 purchased goods and services was not available.

Earlier reporting from 2018 and 2016 indicates significantly higher total emissions, at approximately 528.1 million kg CO2e and 547.2 million kg CO2e respectively. However, detailed breakdowns by scope were not provided for these years.

Bausch Health Companies Inc. has set near-term science-based targets through the Science Based Targets initiative (SBTi), approved for an SME. BHC Ltd commits to a 42% reduction in Scope 1 and Scope 2 greenhouse gas emissions by 2030, using 2020 as a base year. The company also commits to measuring and reducing its Scope 3 emissions. These targets are classified as absolute and align with reductions required to keep warming to 1.5°C. The provided data indicates that these targets are cascaded from Bausch Health Companies Inc. as the ultimate parent organization.